Melola Discovery

← Melola Discovery

Journal SINTA 1

HORMONAL STATUS (ESTROGEN RECEPTORS - PROGESTERONE) AND HER-2 Neu IN VARIOUS CYCLIN D1 EXPRESSIONS IN BREAST CANCER

Folia Medica Indonesiana · Vol. 46 No. 4 (2010)

ISSN
2355-8393, 2599-056X
Published
2010-10-01
Publisher
Airlangga University
Language
en

Abstract

Breast cancer is the most common malignancy and leading death cause of malignancy in women in the world. Expression of estrogen receptors (ER) and progesterone receptors (PR) has long been used to determine endocrine therapy patients. Family of human epidermal growth factor receptor, namely (HER-2/neu) has been used as markers to predict prognosis and therapy response. But many ductal breast carcinoma patients showed expression of ER, PR, and HER-2 neu negative (triple negative tumors). There should be further research for patients with triple negative tumors, to find prognostic markers and therapies. The purposed of this study was to analyze the relationship between hormonal status and HER-2 expression with cyclin D1expression in breast ductal carcinoma. This study was an observational analytic study, conducted at the Department of Pathology Faculty of Medicine Airlangga University/Dr. Soetomo. Paraffin blocks of 35 patients with invasive ductal breast carcinoma, which has not been treated with anti-cancer drug, in a variety hormonal status and HER-2 neu expression, followed by immunohistochemical examination. The results obtained, 31.4% patients in the age group 50 to 59 years. Cyclin D1 positive expression in 54.3% samples, and positive in 87.5% samples with ER positive and negative in 55.6% samples with negative ER. In positive PR sample, cyclin D1 positive in 72.7% samples, and cyclin D1 negative in 54.2% samples with negative PR.. Also showed that cyclin D1 positive in 85.7% samples with HER-2 positive and negative in 66.7% samples with HER-2 negative. In conclusion, there is a positive correlation between expression of ER and HER-2 neu by cyclin D1 expression.

Keywords

Collaboration network of the authors

36 authors · 143 co-authorship links · 27 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Airlangga
  • Universitas Katolik Widya Mandala Surabaya
  • Rumah Sakit Dokter Soetomo
  • Tadulako University
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Anny Setijo RahajuUniversitas Airlangga3
Junaidi KhotibUniversitas Airlangga3
Gondo MastutikUniversitas Airlangga2
Alphania RahniayuUniversitas Airlangga2
Mahardian RahmadiUniversitas Airlangga2
Bernadette Dian NovitaUniversitas Katolik Widya Mandala Surabaya2
Budi HarjantoRumah Sakit Dokter Soetomo1
Dewi Perwito SariUniversitas Airlangga1
Sjahjenny MustokoweniUniversitas Airlangga1
Rahmi AliaAffiliation unknown1
Selvi MegawatiUniversitas Airlangga1
Yuyun WirasasmitaTadulako University1
Novalia Chumaladewi GuntarnoUniversitas Airlangga1
I Ketut SudianaUniversitas Airlangga1
Sianty DewiUniversitas Katolik Widya Mandala Surabaya1
Vicky Sumarki BudipramanaUniversitas Airlangga1
Ferdinand ErwinUniversitas Katolik Widya Mandala Surabaya1
Hari Basuki NotobrotoUniversitas Airlangga1
Hendrian Dwikoloso SoebagjoUniversitas Airlangga1
Ismi ZuhriaUniversitas Airlangga1
Dwita PermatasariUniversitas Airlangga1
Cinintha NandiniUniversitas Airlangga1
Yudy TjahjonoUniversitas Katolik Widya Mandala Surabaya1
I Gede Putu Adhi WedhargaUniversitas Katolik Widya Mandala Surabaya1
Hendy WijayaUniversitas Katolik Widya Mandala Surabaya1
Sianty DewiUniversitas Katolik Widya Mandala Surabaya1
Martha ErvinaUniversitas Katolik Widya Mandala Surabaya1
Irene Lingkan ParengkuanUniversitas Katolik Widya Mandala Surabaya1
Yufita Ratnasari WiliantoUniversitas Katolik Widya Mandala Surabaya1
Herjunianto HerjuniantoUniversitas Katolik Widya Mandala Surabaya1
Sabrina Maria GhasaniUniversitas Katolik Widya Mandala Surabaya1
Michael Christian LimantoroUniversitas Katolik Widya Mandala Surabaya1
Ferdinand Wiliam JayaUniversitas Katolik Widya Mandala Surabaya1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">HORMONAL STATUS (ESTROGEN RECEPTORS - PROGESTERONE) AND HER-2 Neu IN VARIOUS CYCLIN D1 EXPRESSIONS IN BREAST CANCER</dc:title><dc:creator>Imam Susilo</dc:creator><dc:creator>Imelda Theodora</dc:creator><dc:creator>Nila Kurniasari</dc:creator><dc:subject>breast cancer</dc:subject><dc:subject>cyclin D1</dc:subject><dc:subject>estrogen receptor</dc:subject><dc:subject>progesterone receptor</dc:subject><dc:subject>HER2/neu</dc:subject><dc:subject>triple-negative breast cancer</dc:subject><dc:subject>invasive ductal carcinoma</dc:subject><dc:subject>hormonal status</dc:subject><dc:subject>prognostic factors</dc:subject><dc:subject>endocrine therapy</dc:subject><dc:description xml:lang="en">Breast cancer is the most common malignancy and leading death cause of malignancy in women in the world. Expression of estrogen receptors (ER) and progesterone receptors (PR) has long been used to determine endocrine therapy patients. Family of human epidermal growth factor receptor, namely (HER-2/neu) has been used as markers to predict prognosis and therapy response. But many ductal breast carcinoma patients showed expression of ER, PR, and HER-2 neu negative (triple negative tumors). There should be further research for patients with triple negative tumors, to find prognostic markers and therapies. The purposed of this study was to analyze the relationship between hormonal status and HER-2 expression with cyclin D1expression in breast ductal carcinoma. This study was an observational analytic study, conducted at the Department of Pathology Faculty of Medicine Airlangga University/Dr. Soetomo. Paraffin blocks of 35 patients with invasive ductal breast carcinoma, which has not been treated with anti-cancer drug, in a variety hormonal status and HER-2 neu expression, followed by immunohistochemical examination. The results obtained, 31.4% patients in the age group 50 to 59 years. Cyclin D1 positive expression in 54.3% samples, and positive in 87.5% samples with ER positive and negative in 55.6% samples with negative ER. In positive PR sample, cyclin D1 positive in 72.7% samples, and cyclin D1 negative in 54.2% samples with negative PR.. Also showed that cyclin D1 positive in 85.7% samples with HER-2 positive and negative in 66.7% samples with HER-2 negative. In conclusion, there is a positive correlation between expression of ER and HER-2 neu by cyclin D1 expression.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2010-10-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://www.journal.unair.ac.id/filerPDF/14%2011002%20ImamE%20-%20Format%20FMI.pdf</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 46 No 4 (2010)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>